Genmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer Immunotherapies

World News: . []

Genmab may elect to progress any resulting product candidates and will be responsible for development manufacturing and worldwide commercialization For any products that are commercialized by Genmab Immatics will have an option to limited...

More news and information about Genmab A/S

Published By:

Globe Newswire: 02:56 GMT Thursday 12th July 2018

Published: .

Search for other references to "genmab" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us